News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
PPD, Inc. Shares Tumble On Lowered Outlook
April 22, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters - Shares of Pharmaceutical Product Development Inc (PPD) (PPDI.O) fell as much as 22 percent in premarket trade Wednesday, a day after the clinical-research service provider lowered its full-year forecast.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
PPD
MORE ON THIS TOPIC
Regulatory
GSK again pulls application for leucovorin, touted by FDA as potential autism treatment
April 10, 2026
·
2 min read
·
Tristan Manalac
Funding
Novartis-backed Sidewinder collects $137M series B to strike at difficult-to-treat tumors
April 9, 2026
·
2 min read
·
Tristan Manalac
C-suite
Novavax Shareholder Vows To Fight CEO Pay Package, End ‘Dogmatic Leadership’
April 8, 2026
·
3 min read
·
Annalee Armstrong
Mergers & acquisitions
Merck Chopped $1B Off Terns’ Offer After Seeing Updated Leukemia Data
April 8, 2026
·
3 min read
·
Tristan Manalac